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T h e  p o s t - t r a n s la t io n a l  m o d i f ic a t io n  o f  a n  l- to  a  n- 
a m in o  a c id  h a s  b e e n  d o c u m e n te d  in  r e la t iv e ly  fe w  g e n e  
p r o d u c t s ,  m o s tly  in  s m a ll  p e p t id e s  u n d e r  10 a m in o  a c id s  
in  le n g th .  I n  th i s  r e p o r t ,  w e  d e m o n s t r a t e  t h a t  a  4 6 -a m in o  
a c id  p o ly p e p t id e  to x in  h a s  o n e  n -p h e n y la la n in e  a t  p o s i ­
t io n  44, a n d  t h a t  th e  e p im e r iz a t io n  f ro m  a n  L -P he to  a  
D -Phe h a s  a  d r a m a t i c  e f f e c t  o n  th e  e x c i t a to r y  e f f e c ts  o f  
th e  p e p t id e .  I n  o n e  e le c t ro p h y s io lo g ic a l  a s s a y  c a r r i e d  
o u t ,  th e  D -P h e -c o n ta in in g  p e p t id e  w a s  e x tr e m e ly  p o te n t ,  
w h e r e a s  th e  u n m o d if ie d  p o ly p e p t id e  h a d  n o  b io lo g ic a l  
a c t iv i ty ,  d e m o n s t r a t in g  t h a t  th e  c h i r a l i ty  o f  th e  p o s t-  
t r a n s la t io n a l ly  m o d if ie d  a m in o  a c id  is  f u n c t io n a l ly  s ig ­
n i f ic a n t .  T h e  p e p t id e  to x in  a n a ly z e d ,  r l l a ,  b e lo n g s  to  th e  
I -g e n e  s u p e r f a m i ly  o f  c o n o to x in s  t h a t  h a s  f o u r  d is u lf id e  
c ro s s - l in k s . T h e  n -P h e  in  r l l a  is  a t  th e  t h i r d  a m in o  a c id  
f ro m  th e  C  te r m in u s ,  th e  s a m e  r e l a t i v e  p o s i t io n  f ro m  th e  
C - te r m in a l  e n d  a s  th e  n -a m in o  a c id  in  to -a g a to x in  T K  
f ro m  a  s p id e r ,  a n  u n r e l a t e d  p e p t id e .  T h u s , a l th o u g h  
p o s t - t r a n s la t io n a l  a m in o  a c id  is o m e r iz a t io n  a p p e a r s  to  
h a v e  n o  s t r o n g  s p e c if ic i ty  f o r  th e  c h e m ic a l  n a t u r e  o f  th e  
a m in o  a c id  s id e  c h a in ,  th e  fe w  p e p t id e s  w h e r e  th i s  m o d ­
i f ic a t io n  h a s  b e e n  e s t a b l i s h e d  s u g g e s t  t h a t  t h e r e  m a y  b e  
fa v o r e d  p o s i t io n s  n e a r  th e  N  o r  C  t e r m in u s  t h a t  a r e  
p r e f e r e n t i a l  s i t e s  f o r  is o m e r iz a t io n  to  a  n -a m in o  a c id .
A remarkable post-translational modification of polypeptides 
synthesized on ribosomes is the conversion of a standard i,- 
amino acid into the corresponding n-isomer (1, 2). Most cases of 
post-translational isomerization to n-amino acids have been 
documented in small peptides from vertebrate, arthropod, and 
molluscan systems. This post-translational modification does 
not appear to be specific for a particular amino acid; a variety 
of different amino acids have been post-translationally con­
verted to the n-form. The diverse biological systems in which 
n-amino acid-containing gene products have been character­
ized, and the apparently unrelated sequence contexts in which 
these post-translationally modified amino acids occur raises 
the question of whether such a post-translational modification 
can be predicted.
A difficulty in critically assessing the natural distribution of 
the post-translational isomerization of amino acids is that the 
larger the gene product, the more difficult it becomes to ascer­
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tain the presence of a modified amino acid. In small peptides, 
the effect of converting a single I,- to a n-amino acid can cause 
a significant difference in chromatographic and other proper­
ties; however, as the polypeptide gets larger, converting one 
amino acid residue to the corresponding n-isomer results in 
more subtle global changes. Furthermore, in contrast to all 
other post-translational modifications, isomerization to a n- 
amino acid is not detectable by any of the standard techniques 
used in proteomics, such as mass spectrometry. In order to be 
able to predict when the post-translational conversion to a 
n-amino acid might occur, the identification of more bona fide 
cases of natural polypeptides having a n-amino acid is required.
The first larger peptidic gene product in which a n-amino 
acid was identified was w-agatoxin TK from the funnel spider 
Agelenopsis aperta: a single n-serine was identified toward the 
C-terminal end (3). The only other larger peptide with a n- 
amino acid, also from an arthropod system, was the crustacean 
hyperglycemic hormone, where the amino acid modified is to­
ward the N-terminal end (4-6). There is no similarity at all 
that can be detected between the sequence context of the post­
translational isomerization in these two cases.
Among peptides that have been modified from different 
sources such as frog skin, molluscan nervous tissue, or platy­
pus venom, the n-amino acid is most often located at the second 
position from the N terminus (7-14). However, in the contiy- 
phans, a group of octapeptides from the venom of Conus, the 
n-amino acid is found at the fourth amino acid residue (15-17). 
In both the frog peptides and in the contryphans, the position 
within the peptide seems to be the dominant determinant of 
whether a change in chirality from an i.-amino acid to a n- 
amino acid will occur, rather than the type of amino acid at that 
position.
In this work, we describe the presence of a n-amino acid in a 
member of a recently characterized group of conotoxins, the 
I-superfamily (18). This conotoxin, r lla , is only the third ex­
ample found of a larger polypeptidic gene product, which has 
definitively been shown to have undergone this unusual post­
translational modification. We have synthesized both the i,- 
and the n-amino acid-containing isomers of conotoxin r lla , and 
demonstrate that the presence of the modified amino acid 
causes a marked change in biological activity.
EXPERIMENTAL PROCEDURES
Purification of Conotoxin r l la  from Venom—Crude venom extract 
was prepared as described earlier (15). The extract was loaded onto a 
Vydac Cls semipreparative HPLC1 column and eluted at 5 ml/min with
1 The abbreviations used are: HPLC, high performance liquid chro­
matography; MTBE, methyl-tert-butyl ether; MALDI, matrix-assisted 
laser desorption ionization; HBTLT, 2-(li/-benzotriazole-l-yl)-l,1,3,3- 
tetramethyluronium hexafluorophosphate; DIEA, iV,iV-diisopropyl-eth- 
ylamine; i.e., intracranially; MS, mass spectrometry.


























a gradient of solvent A (0.1% trifluoroacetic acid) and solvent B90 
(0.085% trifluoroacetic acid in 90% acetonitrile). Further purification 
was done on a Vydac Cla analytic column at a flow rate of 1 ml/min.
Mass Spectrometry—Matrix-assisted laser desorption ionization 
(MALDI) mass spectra were obtained using a Voyager DE STR mass 
spectrometer, courtesy of the Mass Spectrometry and Proteomic Core 
Facility. University of Utah. Alternatively. MALDI spectra were ob­
tained using a Bruker REFLEX time-of-flight mass spectrometer 
(Bruker Daltonics) fitted with a gridless reflectron, an N2 laser, and a 
100 MHz digitizer, courtesy of the Salk Institute for Biological Studies 
(La Jolla. CA).
Peptide Synthesis—Peptides were synthesized on solid support by an 
automated peptide synthesizer using iV-Fmoc (iV-(9-fluorenyl)methoxy- 
carbonyl) -protected amino acids. HBTU and DIEA (19). courtesy of Dr. 
Robert Schackmann of the DNA/Peptide Facility. University of Utah. 
All cysteine residues were trityl-protected. The coupling time was 1 h. 
Peptide cleavage/deprotection was accomplished with reagent K(82.5% 
trifluoroacetic acid. 5% phenol. 5% H„0, 5% thioanisole, 2.5% 1,2- 
ethanedithiol) for 2 h at room temperature. Soluble crude peptides were 
precipitated with cold MTBE and centrifuged. The pellet was washed 
with MTBE. centrifuged again, then dissolved in 25% acetonitrile in
0.1% trifluoroacetic acid, and lyophilized. The linear peptides were 
purified on a Vydac Cla semipreparative HPLC column.
Oxidative Folding—Oxidative folding of peptides was done with 0.1 M 
Tris-HCl. pH 8.7. containing 1 mM EDTA. 1 mM GSSG. and 1 mM GSH 
at room temperature for 3 h. The reaction was initiated by adding the 
linear synthetic peptide to a final concentration of 20 /lim, then 
quenched by adding formic acid to a final concentration of 8%. The 
oxidized form was purified on a Vydac Cla HPLC column with a gradi­
ent of 15-60% solvent B (0.1% trifluoroacetic acid in 90% acetonitrile) 
for 40 min.
Reduction and Alkylation—Two nanomoles of peptide were dissolved 
in 40 /ni of 50% acetonitrile in 0.1% trifluoroacetic acid, and reduced by 
addition of 10 /ni of reduction buffer (0.5 M Tris acetate. pH 8.0. con­
taining 5 mM EDTA and 100 mM dithiothreitol) and incubation at 65 °C 
for 30 min. The peptide was then alkylated with 40 /ill of 0.5 M iodoacetic 
acid in 0.5 M Tris acetate. pH 8.0, containing 5 mM EDTA in the dark at 
room temperature for 30 min. The reaction mixture was applied to a 
Vydac Cla analytical HPLC column and eluted with 30% solvent B for 
15 min followed by a gradient of 30—55% solvent B for 25 min.
Digestion with Endoprotei.na.se Asp-N—Both natural and synthetic 
conotoxin r l l a  were digested with endoproteinase Asp-N (Roche Ap­
plied Science) to generate fragments. Two nanomoles of the reduced and 
alkylated peptide were dissolved in 4 /ni of 30% acetonitrile and added 
to 36 id of endoproteinase Asp-N solution (2.8 ug/ml in 50 mM Tris-HCl. 
pH 7.5) to yield an enzyme/substrate ratio of 1:100 (w/w). After 2 h of 
incubation at 35 °C. the reaction was stopped by addition of 40 /ill of 0.1 
M EDTA. The digestion products were separated on Vydac Cla analyt­
ical HPLC column using a gradient of 5-50% solvent B for 45 min. The 
digestion products were analyzed by MALDI mass spectrometry.
Digestion with Chymotrypsin—Natural and synthetic conotoxin r l la  
were digested with sequencing-grade chymotrypsin (Roche Applied Sci­
ence). Two nmol of alkylated peptide were dissolved in 4 /liI of 30% 
acetonitrile and added to 34 /d of chymotrypsin solution (5.6 ug/ml in 50 
mM Tris-HCl. pH 7.5) to yield an enzyme/substrate ratio of 1:50 (w/w). 
After 12 h of incubation at room temperature, the digestion products 
were separated on a Vydac Cla analytical HPLC column, using a gra­
dient as for endoproteinase Asp-N digestion products, and then ana­
lyzed by MALDI mass spectrometry. Additionally, peptide fragments 
were sequenced using an Applied Biosystems Model 492 Sequenator. 
courtesy of Dr. Robert Schackmann (DNA/Peptide Facility. University 
of Utah).
Bioassay—Conotoxins were dissolved in normal saline solution 
(NSS) and injected using a 29-gauge insulin syringe. Swiss Webster 
mice (15 days old) were injected intracranially (i.e.) with 20 /ni of the 
conotoxin solution as described previously (20). Control animals were 
similarly injected with NSS. Proper animal care and use protocols were 
followed in accordance with the guidelines set by the University of Utah 
Institutional Animal Care and Use Committee.
Electrophysiology—The cutaneus pectoris muscle preparation of 
Rana pipiens was used as described previously (18). All experiments 
were performed on a single batch of summer frogs purchased from 
Charles D. Sullivan (Nashville. TN). Briefly, the recoding/stimulating 
chamber was made from a silicone elastomer. Sylgard (Dow Corning), 
and consisted of a rectangular trough (about 1 mm x  15 mm x  4 mm 
deep) and an adjacent series of four cylindrical wells (4 mm diameter x  
4 mm deep). The different compartments were separated by 1-mm-wide 
partitions. A mini-muscle preparation (see Ref. 21) was placed in the
trough, and the attached motor nerve was draped into the adjacent 
wells, with the proximal (severed) end of the nerve in the well farthest 
from the trough. Portions of the nerve overlying the partition, and 
therefore exposed to air. were covered with Vaseline. A pair of stimu­
lating electrodes spanned the two wells furthest from the trough, and of 
these two wells, that closest the trough also contained a ground elec­
trode. Pulses. 0.1 ms in duration and 6 V in amplitude, and applied via 
a stimulation isolation unit, were used to stimulate the motor nerve at 
a frequency of 2/min. To record the activity of the muscle, a pair of 
recording electrodes was located in the trough, with one electrode near 
the middle and the other at one end. Activity of the nerve was recorded 
with a second pair of electrodes located in the two wells closest to the 
trough. Each set of recording electrodes were connected to a differential 
A/C amplifier, and the signal bandpass filtered (1 Hz to 3 kHz) and 
digitized at a sampling frequency of 10 kHz. This arrangement allowed 
the electrical activity from nerve and muscle to be recorded simulta­
neously. Homemade software programmed in LabVIEW (National In­
struments. Austin. TX) was used for data acquisition. All electrodes 
were 0.01 diameter stainless steel wires. Solutions in all compartments 
were static and refreshed periodically by manual replacement. Peptides 
were dissolved in frog Ringer’s containing 0.1 mg/ml bovine serum 
albumin. To apply peptide, the fluid in the muscle-containing trough 
was removed and replaced with peptide at the indicated concentration. 
The solution was stirred by aspirating the solution into the tip of a 
pipettor. then discharging it back out into the trough, for 20 cycles. 
During this solution exchange and stirring, the inputs of the recording 
amplifiers were grounded for protection. The entire process took be­
tween 1.5 and 2 min and accounts for the hiatus in the records in Fig.
4. All recordings were performed at room temperature ( -21 °C).
RESULTS
Non-identity of Synthetic. Conotoxin (All l  Version) and Nat­
ural Conotoxin rlla: Preliminary Evidence Suggesting the. 
Presence of a n-Amino Acid—The excitatory conotoxin r l la  
which belongs to the I-superfamily is a relatively large cono­
toxin (46 amino acids ) with four disulfide bonds, purified from 
the venom of the piscivorous species Conus radiatus. The pu­
rification of the natural conotoxin used in the studies described 
below was carried out by a modification of the method de­
scribed previously (18). C. radiatus venom has at least 18 
different I-superfamily peptides; all that have been purified 
from venom are excitatory. A major challenge in purification is 
the separation of one isoform from another. As shown in Fig. 1, 
peptide r l la  was purified to homogeneity, but this required 
four reverse-phase HPLC runs to separate the peptide from 
contaminating isoforms.
The linear peptide with all i,-amino acids was chemically 
synthesized and folded, and the resultant synthetic peptide 
was shown to elicit excitatory biological activity. However, a 
biochemical characterization of folded synthetic peptide re­
vealed that it did not co-elute with the natural peptide. When 
the natural peptide was reduced, the linear synthetic peptide 
and the linear natural peptide also did not co-elute. However, 
the mass value of the synthetic material was identical to that of 
the natural peptide. A preliminary functional characterization 
indicated that the synthetic peptide, though biologically active, 
was not as potent as natural r lla . Together, these initial data 
raised the possibility that a n-amino acid residue might be 
present in the natural conotoxin r lla .
In order to further explore this possibility, both the reduced 
and alkylated synthetic (all I, version) and natural peptides 
were digested with endoproteinase Asp-N as described under 
“Experimental Procedures.” After digestion with the endopro­
teinase, the products were analyzed by HPLC. Three digestion 
products were identified by mass spectrometry. These were the 
predicted end digestion products of endoproteinase Asp-N (Fig. 
2A): an N-terminal heptapeptide (P2), a nonapeptide from res­
idues 8 to 16 (PI) and a large C-terminal fragment from resi­
dues 17 to 46 (P3). The two smaller peptides from synthetic and 
natural r l la  were identical in their elution properties on 

























Fig. t. P u r if ic a t io n  o f  n a tu r a l  co n o to x in  r l l a .  A, fractionation of 
crude extract from C. radiatus venom on a Cla semipreparative HPLC 
column eluted with a gradient of 0-60% solvent B90 (0.085% trifluoro­
acetic acid in 90% acetonitrile) over 120 min at a flow rate of 5 ml/min. 
The arrow indicates the fraction with r l la ,  and the dotted line indicates 
the acetonitrile gradient. B, elution of the fraction marked by an arrow 
in A  using a Cla analytical column with a gradient of 20-40% B90 over 
50 min at 1 ml/min flow rate. C, further purification of the fraction 
indicated by an arrow in B using a gradient of 30-55% B90 over 25 min 
at 1 ml/min. D, purification of the fraction marked by the arrow in C 
using the same gradient and flow rate.
natural peptide for P3, the large C-terminal product. This 
indicated that any n-amino acid(s) were likely to be between 
amino acids 17 and 46.
The reduced and alkylated natural and synthetic linear pep­
tides yielded different products upon digestion with chymotryp­
sin (Fig. 2B). For the synthetic peptide, four different digestion 
products were obtained. A combination of mass spectrometry 
and Edman sequencing was used to identify the cleavage prod­
ucts. This analysis revealed that chymotrypsin cleavage after 
Trp33 and Phe44 had occurred on the synthetic peptide, but that 
the digestion at these loci was incomplete. Thus, two of the 
predicted digestion products, the fragments from amino acids 1 
to 33 (P4) and 34 to 44 (P5) were obtained, as well as two 
incomplete digestion products (1-44 (P7) and 34 -46  (P6)). 
However, when a similar digestion of the natural peptide was 
carried out, a strikingly different pattern was obtained. No 
digestion after Phe44 was detected, and only fragments from 1 
to 33 and a new fragment whose sequence and mass value were 
consistent with AA 34 to 46 (P6, dashed line) were obtained. 
However, although the mass of the peptide was consistent with 
residues 34-46, this peptide fragment did not co-elute with the 
corresponding fragment from the synthetic r lla . These results 
are consistent with the presence of a n-amino acid in the inter­
val from amino acids 34 to 46.
We reasoned that if residue 44 were in fact a n-amino acid, 
the failure of chymotrypsin to cleave after Phe44 in the natural 
peptide would be explained. Thus, together, the data led us to 
the specific working hypothesis that natural conotoxin r l la  
differs in having a n-phenylalanine residue at position 44, 
instead of the i,-Phe in the synthetic peptide.
Direct Verification of the. Presence of a n-Amino Acid in rlla  
by Chemical Synthesis—The hypothesis that r l la  contains a 
n-phenylalanine residue at position 44 was directly tested by
Fig. 2. D ig e s tio n  o f  sy n th e tic  [ i , - P h e " ] r l l a  a n d  n a tu r a l  r l l a ,  
a s  d e sc r ib e d  u n d e r  “E x p e r im e n ta l P ro c e d u re s .” Peaks denoted by 
solid lines and dashed lines are products from synthetic and natural 
r l la ,  respectively. Arrows indicate cleavage sites by the enzymes. A, 
end products of digestion with endoproteinase Asp-N. B, end products of 
digestion with chymotrypsin.
chemical synthesis. Peptide P6 with amino acids from 34 to 46 
was chemically synthesized with both i,-Phe44 and n-Phe44; 
when these synthetic peptides were chromatographed with the 
corresponding chymotrypsin fragment from natural r lla , only 
the n-Phe44 peptide co-eluted, and the i,-Phe44 peptide was 
resolved from the natural 34-46 fragment.
These results led us to synthesize the entire peptide r l la  as 
described under “Experimental Procedures.” An all I, version 
and a n-Phe44 version of the r l la  primary sequence were syn­
thesized, and both peptides were folded. As is shown in Fig. 3, 
only the n-Phe44-containing conotoxin r l la  co-eluted with the 
natural peptide. This provides direct biochemical evidence that 
Phe44 is post-translationally modified from an I,- to a n-amino 
acid in the natural conotoxin. Thus, the correct amino acid 
sequence of the conotoxin r l la  is: GOSFCKADEKOCEYHAD- 
CCNCCLSGICAOSTNWILPGCSTSSF/TKI, where F is n-phe- 
nylalanine. We refer to the n-Phe44 version of the peptide 
simply as r l la  and the all I, version as [i,-Phe44Jrlla.
Biological Activity of Synthetic Peptides r lla  and 
[i-Phe44]rlla—A  functional comparison of the folded r l la  an­
alogs with different chirality at position 44 was carried out both 
by an electrophysiological characterization with an in vitro 
nerve-muscle preparation from frog, as well as by using an in 
vivo behavioral assay on mice. Unlike either natural or syn­
thetic r lla , both of which induce repetitive activity in the 
amphibian nerve-muscle preparation at concentrations as low 
as 0 .1  /am (see below), no repetitive activity was seen with 
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Fig. 3. A, HPLC chromatograph of natural rl la  (0.7 nmol). B, HPLC 
analysis of a mixture o fl nmol of synthetic U ,-Phe"lrlla and 0.7 nmol 
of natural r l la ;  the peaks are indicated by S and N, respectively. C', 
co-elution of natural (0.5 nmol) and synthetic (0.5 nmol) conotoxin rl la  
(with n-Phe"). The elutions were done using a Cla analytical column 
with a gradient of 30-55% B90 over 25 min at 1 ml/min flow rate.
using the in vitro frog nerve-muscle preparation, the natural 
D-Phe form of the peptide is >250-fold more potent than the 
i,-Phe form. However, when a whole animal behavioral assay 
(with 15-day-old mice) was used to assess the D-Phe and i,-Phe 
forms of r lla , a smaller differential (10- 20-fold) was observed 
in potency of the D-Phe and i,-Phe r l la  analogs. This estimate 
is based on comparing the dose in which hyperactivity symp­
toms but no death occurred (5 versus 100 pmol for the d- and 
i,-Phe forms), as well as the doses in which marked hyperac­
tivity was followed by death some minutes later (20 versus 250 
pmol for the d- and i,-Phe forms). Thus, using two very different 
assays, the natural D-Phe r l la  peptide is significantly more 
potent than the i,-Phe r l la  analog.
Comparison of the Activity of Native and Synthetic Peptides 
r lla —The ability of the natural r l la  to elicit trains of action 
potentials in an isolated nerve-muscle preparation from frog 
was previously reported (18). Normally, action potentials are 
not seen in skeletal muscle unless the nerve is stimulated; that 
is, spontaneous action potentials are not seen. Furthermore, a 
single stimulus applied to the motor nerve usually produces 
only a single action potential in the muscle. However, in the 
presence of I-superfamily conotoxins both evoked and sponta­
neous trains of action potentials are observed. This is the case 
for both natural and synthetic r lla . The effects produced by 
the peptides were comparable in several respects: 1) On-rate. 
At a concentration of 1 /am, both peptides induced repetitive 
activity within a minute of their application. However, at lower 
concentrations, the first signs of repetitive activity took several
minutes to appear (see Fig. 4 for examples). At 100 iim, the 
mean (±S.D.) induction time in three trials with each peptide 
was 3.8 ± 0.8 min for the natural peptide and 4.9 ± 2.2 min for 
the synthetic peptide. Thus, within experimental error, the 
peptides have the same on-rate. 2) Off-rate. The repetitive 
activity induced by both peptides persisted for >18 h following 
their washout. Thus, the effect of both peptides is relatively 
irreversible. 3) When the peptide-induced activities are simul­
taneously recorded in nerve and muscle, it was observed that 
each action potential in the muscle is preceded by an action 
potential in the nerve. This was originally reported for the 
native peptide (18) and is also seen with the synthetic peptide 
(Fig. 5). This indicates that with both natural and synthetic 
peptides, repetitive activity is primarily induced in the motor 
nerve and only secondarily in the muscle. That is, the peptide 
induces repetitive activity in the motor nerve, and this activity 
is conveyed to the muscle via synaptic transmission. As would 
be expected, when synaptic transmission is blocked by exposing 
the preparation to 5 /am d-tubocurare, an acetylcholine recep- 
tor-antagonist, repetitive activity in the muscle, but not in the 
nerve, is blocked (not illustrated).
DISCUSSION
The studies above have demonstrated the presence of an 
unusual post-translationally modified amino acid, D-phenylala- 
nine, at amino acids 44 of r lla , a conotoxin with eight Cys 
residues and 46 amino acids. This is the first multiple disulfide- 
bonded conotoxin shown to contain a D-amino acid. The post- 
translational modification is important for optimal biological 
activity of the toxin.
D-Amino acids have a sporadic distribution in a number of 
biological systems. These have been characterized mostly in 
smaller peptides (for a comprehensive review on D-amino acids 
see Ref. 2), most notably those produced by frog skin, as well as 
by various invertebrate and mammalian sources. D-amino acids 
were described previously in the contryphans, a family of small 
peptides, which are widely distributed across the genus Conus 
(15-17). These small peptides (typically, eight amino acids) 
have a single disulfide bond; most have either a D-tryptophan 
or D-leucine residue (Table I). The contryphans were notable 
biochemically because of the slow equilibration between two 
conformational states exhibited by many of these peptides; the 
presence of a D-Trp residue was required for the slow confor­
mational equilibrium.
The notable feature of the I-conotoxin superfamily, to which 
conotoxin r l la  characterized above belongs, is the large number 
of different molecular isoforms differing in their primary se­
quences that can be present in a single venom. Conotoxin r l la  is 
from the venom of C. radiatus, which is believed to be fish- 
hunting species. More than 20 distinct I-superfamily conotoxins, 
each significantly different in sequence, are expressed by C. radi­
atus. However, these share different extents of homology to the 
D-phenylalanine-containing conotoxin r l la  characterized in this 
report. The modified phenylalanine residue is conserved in a 
subset of several I-superfamily conotoxins from C. radiatus and 
other Conus species, strongly suggesting that at least the mem­
bers of this subset of I-superfamily conotoxins undergo the post- 
translational isomerization at this locus. The amino acids pre­
ceding the D-Phe residue are part of a conserved sequence motif, 
—GCSTSSFF—( where F is the D-Phe residue) (18).2
We have demonstrated that the D-Phe residue is important 
for the biological activity of conotoxin r lla . I f  an i,-Phe, instead 
of a D-Phe is present, the peptide is significantly less active as 
an excitotoxin. A comparison of native and synthetic D-Phe- 
containing peptides was carried out. Since the effects of both

























F ig. 4. C o m p a riso n  o f n a tu r a l  versus sy n th e tic  r l l a .  Responses were obtained simultaneously from muscle and nerve every 30 s, except 
during solution change. Successive responses are shown from bottom to top, before (lowest trace) and during (remaining traces) exposure to 100 nM 
of native r t t a  (panels A l  and A2) or synthetic r t ta  (BI and B2). The gap between the lowest trace and the one immediately above it reflects the 
time it took to apply the peptide (see “Experimental Procedures"). Vertical and horizontal units are mV and ms, respectively. Responses from nerve 
(panels A2 and B2) are shown at high amplification; thus, the repetitive action potentials, which are from individual axons, are clearly seen at the 
expense of truncating the evoked compound action potential. The latter is seen in each panel immediately following the nerve stimulus, which was 
applied after 20 ms from start of each trace. To enhance readability, every other trace is shown in gray. The first trace to show repetitive activity 
occurred after about 4 min for the natural peptide and after about 3 min for the synthetic peptide. The small action potentials in panel B2, evident 
in all traces, represent sensory stretch receptor activity (see Ref. 18); note that the peptide-induced action potentials are larger, and these large 
action potentials are correlated with corresponding events in the muscle (see also Fig. 5).
native and synthetic peptides are relatively irreversible, equi­
librium dose-response measurements could not be obtained. 
Instead, as an index of toxin potency, the time interval between 
the administration of peptide and the first observation of re­
petitive activity (the induction time) was used. Higher concen­
trations of peptide had shorter induction times. At the same 
concentration, native and synthetic peptides had similar induc­
tion times. Furthermore, both peptides targeted channels in 
the nerve, rather than the muscle. Thus, both natural and 
synthetic peptides have comparable potencies and specificities. 
These functional features, along with their chemical character­
istics, lead us to conclude that the natural and synthetic r l la  
are identical.
Although all of the I-superfamily peptides characterized so 
far appear to be excitotoxins, and several have been shown to 
target K channels in animals as diverse as mammals and stem 
chordates (22), it remains to be established which of the I- 
superfamily members (that all share the same Class 11 Cys
pattern found in r lla )  also contain n-amino acids. The discov­
ery of a n-amino acid in conotoxin r l la  introduces a cautionary 
note into using standard genetic/proteomic methods to investi­
gate conotoxins: although the sequence of r l la  and other I- 
superfamily conotoxins can be readily derived by PCR/cloning, 
and the number of hydroxylated Pro residues can be deduced 
by mass spectrometry, the presence of a n-amino acid would 
have eluded both of these methods.
We note that although the sequence of conotoxin r l la  has no 
apparent homology to the w-Aga-TK spider toxin, and the 
amino acids modified are different (Phe versus Ser), the locus of 
modification is the same distance from the C terminus (see 
Table I, A). In conotoxin r lla , which has 46 residues, it is a Phe 
residue at amino acid 44; in w-Aga-TK, which has 48 residues, 
it is a Ser residue at amino acid 46. The characterization of a 
n-amino acid in conotoxin r l la  raises the possibility that the 
third amino acid from the C terminus may be a favored site. 























Post-translational Conversion o f  to D-Phe
Fig. 5. R e p e titiv e  re sp o n se s  re c o rd e d  s im u lta n e o u s ly  in  n e rv e  a n d  m u sc le . Repetitive action potentials induced by 100 nM natural (A) 
and synthetic (B) peptides. Note that for both panels, each action potential in the muscle recording (lower trace) has a corresponding action 
potential that just precedes it in the nerve recording (upper trace). Calibration sale of 0.025 mV is for nerve, and 0.5 mV is for muscle.
Table I
Peptides containing n-amino acids
A. Peptides with a D-amino acid at position 3 from the C terminus
Peptide Sequence Source Ref.
w-Agatoxin TK EDNCIAEDYGKCTWGGTKCCRGRPCRCSMIGTNCECTPRLIMEGLSFAa Agelenopsis aperta (3)
r l l a  GOSFCKADEKOCEYHAJDCCNCCLSGICAOSTNWILPGCSTSSFFKF,b-'e C. radiatus This work
Achatin-I GFADa‘! Achatina fulica (8)
B. Peptides with a D-amino acid at position 2 from the N terminus
Peptide Sequence Source Ref.
Fulicin FNEFVa-<* Achatina fulica (11)
Achatin-I GFADai Achatina fulica (8)
Mytilus-FFRF amide ALAGDHFFRF^ Mytilus edulis (12)
Dermorphin YAFGYPSa<* Phyllomedusa sauvagei (7)
Met-deltorphin YMFRLMDa-d Phyllomedusa sauvagei (9, 10)
Platypus peptide LLHDHPNPRKYKPANKKGLSKGCFGLKLDRIGSTSGLGCa Ornithorhynchus anatinus (13, 14)
C. Peptides with a D-amino acid at position 4 from the N terminus
Peptide Sequence Source Ref.
Contryphan-R GCOWEPWea'6<* C. radiatus (15)
Contryphan-Sm GCOW QPW O  b,d Conus stercusmuscarum (16)
Leu-Contryphan-P GCVLLPWCa-'<! Conus purpurascens (17)
° The underlined letter indicates n-isomers. 
6 O, 4-fra«s-hydroxyproline.
C-terminal free acid. 
rf C-terminal amidation.
I-superfamily conotoxin, with a Leu residue at the third posi­
tion from the C terminus, has a D-Leu in the native peptide.3 It  
is noteworthy that in Table I, A-C, examples of peptides from 
different phyla are shown (Agelenopsis is a spider and Conus is 
a mollusc; Achatina and Mytilus are molluscs; Phyllomedusa is 
a frog; Ornithorhynchus is a platypus). This broad phylogenetic 
distribution, combined with the preferential loci of the amino 
acids modified, suggests that this post-translational isomeriza­
tion, which occurs in many animal taxa, may be carried out by 
enzymatic systems that may be specific for a particular amino 
acid locus rather than the chemical nature of the amino acid 
isomerized.
A sum m ary  of th e  n a tu ra l occurrence of D-amino acids in
polypeptides is shown in Table I. The evidence that D-amino 
acids found in most polypeptides are formed post-translation- 
ally has been reviewed (2). In many cases, mRNA encoding a 
precursor for the peptide containing the D-amino acid was 
identified. (The first peptide where post-translational modifi­
cation was definitely established was dermorphin in 1987 by 
Gunther Kreil’s laboratory (23).) The codon specifying the 
standard i,-amino acid is found in the mRNA sequence at the 
locus for the corresponding D-amino acid, suggesting conven­
tional translation by ribosomes, followed by post-translational 
isomerization. Enzymatic activities have been purified both 
from spider venoms (24) and from frog skin secretions4 that 
specifically convert one i,-amino acid to the D-amino acid in the
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peptide precursor. The n-amino acids found in conotoxins are 
therefore presumed to be produced post-translationally. In 
most cases, the relevant cDNA clones encoding these conotox­
ins with n-amino acids have been identified.
It is noteworthy that C. rad ia tus, the organism used for the 
present study, is the first in which two post-translationally 
modified polypeptides have been characterized that differ in 
their n-amino acids (Phe in the present peptide, Trp in contry- 
phan-R), as well as in the loci in which these n-amino acids are 
found on the polypeptide chain. This raises the possibility that 
different enzymatic activities catalyze the isomerization from 
i,- to n-amino acids in the two C. rad ia tu s  peptides; whether 
these are related to the factors identified in the spider and frog 
systems remains to be established.
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